Vitamin D and its metabolites. Advances in the diagnosis and treatment of rickets

Acta Vitaminol Enzymol. 1982;4(1-2):1-11.

Abstract

Diagnostic and therapeutical uses of vitamin D3 and its metabolites are reviewed. Special emphasis is dedicated to the fetomaternal relationships of 1,25 (OH)2 D3 and 25-OH-D3 at term. The serum levels of 1,25 (OH)2 D3 have been found to be higher in the maternal serum then in the corresponding fetus (85.3 pg/ml and 50.9 pg/ml, respectively). The highest serum levels of 1,25 (OH)2 D3 were found in October and the lowest ones in January showing that there is a dependence on the ultraviolet light. It has been found that there is a correlation between the fetomaternal serum levels of 1,25 (OH)2 D3 and 25-OHD. However, there is no correlation between the serum levels of 1,25 (OH)2 D3 and 25-OHD3, neither in the fetus nor in the mother.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Calcifediol / blood
  • Calcifediol / therapeutic use
  • Calcitriol / blood
  • Calcitriol / therapeutic use
  • Child
  • Cholecalciferol / metabolism
  • Cholecalciferol / therapeutic use*
  • Female
  • Fetal Blood / metabolism
  • Fetus / metabolism
  • Humans
  • Hypophosphatemia, Familial / drug therapy
  • Infant
  • Infant, Newborn
  • Nutritional Requirements
  • Pregnancy
  • Rickets / diagnosis
  • Rickets / drug therapy
  • Rickets / therapy*
  • Seasons
  • Ultraviolet Rays
  • Vitamin D Deficiency / therapy*

Substances

  • Cholecalciferol
  • Calcitriol
  • Calcifediol